Sign in

Sukrit Singh

@sukritsingh92.bsky.social
3.1K followers 1.2K following 52 posts

Incoming Assistant Professor at Fox Chase Cancer Center | Damon Runyon QB+ NCI Early Stage K99/R00 Fellow at MSKCC | @foldingathome.org | Systems biophysics, Drug resistance, Protein dynamics, Variant effects, Dogs 🇮🇳🇸🇬🇺🇸 Lab website: singhlab.bio

PostsRepliesMedia
Sukrit Singh @sukritsingh92.bsky.social · 23/09/2026
📣 New preprint 🧪 Physical priors improve performance of structure-based binding affinity models Mtenn decomposes binding affinity prediction into Representation, Strategy, and Readout. E(3)-invariance & splitting components into separate embeddings improves performance! doi.org/10.64898/202...
071
Sukrit Singh @sukritsingh92.bsky.social · 15/09/2026
📣 The Singh Lab opens at Fox Chase Cancer Center in Spring 2027, where I will be starting as an Assistant Professor!📣 Excited to continue studying how protein biophysics shapes drug response. I am hiring across all levels and disciplines! Apply on the "Join" page ( & spread the word!): singhlab.bio
0156
Sukrit Singh @sukritsingh92.bsky.social · 03/08/2026
📣 ❗2nd Preprint of the Summer ❗ 📣 "Kinase inhibitors can change protonation or tautomeric state upon binding." LInk: doi.org/10.64898/202... We find that kinase-inhibitors can change in net-charge and tautomer state upon binding (from solution-state to kinase-bound), affecting med-chem choices!
063
Reposted by Sukrit Singh
Jeremy Berg @jeremymberg.bsky.social · 24/07/2026
SO if they want to experiment with how science is conducted in the United States, they should make substantial donations to a foundation that would open up transparent competitions for funding, in partnership with federal agencies (with minimal strings attached other than process-related ones). 3/5
1144
Reposted by Sukrit Singh
Vincent Voelz @voelzlab.bsky.social · 12/07/2026
In collaboration with Jiwon Seo‘s group at GIST, we are pleased to be co-authors on a new paper describing the structure of peptoid oligomers in nonpolar solvent! doi.org/10.1021/acs.... 1/n
doi.org
Noncanonical Folding of Peptoid Oligomers: Formation of a Closed Conformation in Nonpolar Solvent
Conformational behavior of peptoids in low-dielectric solvents remains poorly understood despite its relevance to membrane environments. Here, conformations of N-(S)-1-phenylethylglycine (Nspe) homo-o...
182
Sukrit Singh @sukritsingh92.bsky.social · 07/07/2026
New preprint! Do all kinase domains have similar activation mechanisms? We steer AlphaFold2 using "transfer seeding" of known kinases to sample 8.3 ms of MD simulations via Folding@home. We find unique pathways that are kinase-specific and depend on different elements! Link: doi.org/10.64898/202...
1237
Sukrit Singh @sukritsingh92.bsky.social · 23/06/2026
Now out in the Special Issue on "New Concepts in Drug Discovery: Drug residence time!" Edited by Markus Seeliger & Ruth Nussinov, the reviews cover new computational and experimental methodologies for predicting ligand affinity & kinetics. Link: www.sciencedirect.com/special-issu...
053
Reposted by Sukrit Singh
Don Moynihan @donmoyn.bsky.social · 01/06/2026
A proposed Trump policy would put Russ Vought in charge of American science. Its an example of the slow creep of politicization into processes that both parties traditionally understood as needing nonpartisan and expert guidance. What can you do about it? 🧵 donmoynihan.substack.com/p/the-creep-...
donmoynihan.substack.com
The Creep of Politicization
A new assault on science highlights a broader pattern
621119493
Sukrit Singh @sukritsingh92.bsky.social · 02/04/2026
More protein-ligand data are needed for AlphaFold-like models (& AI/ML) to enable prospective design! Check out our piece in "Current Opinion in Structural Biology" – Equal parts a thank-you-letter to the PDB & summarizes how datasets will enable task-focused models! Link: doi.org/10.1016/j.sb...
Diagram titled ‘Protein–Drug Prediction Task Breakdown’ showing a hierarchical tree of modeling tasks. Top branches include apo monomer and protein–protein interactions, with sub-branches such as ensembles, induced-fit models, multimers, folded–unfolded complexes, and protein–ligand complexes with mutation effects on binding. Additional branches include potency, ADMET properties (e.g., solubility and blood–brain barrier penetration), and kinetics (e.g., koff). A legend indicates model maturity levels: solid lines (established), dashed lines (promising), and dotted lines (untapped).
2125
Sukrit Singh @sukritsingh92.bsky.social · 13/03/2026
"Reject doomscrolling. Embrace naptime"
A dark brown dog with a graying muzzle stands on a couch, facing the camera with wide, shiny eyes and its tongue playfully sticking out. The dog wears a collar with tags, and a pink blanket is draped beside it. Soft daylight from a nearby window illuminates the cozy indoor scene.
0100
Reposted by Sukrit Singh
Katie Langin @klangin.bsky.social · 26/01/2026
How many STEM Ph.D.s were lost from the U.S. federal government last year? My colleagues @mghersher.bsky.social and @policyhound.bsky.social dug into a recent data release to find the answer. A @science.org exclusive. www.science.org/content/arti...
4273149
Reposted by Sukrit Singh
Dr Kathleen Millen @neurodevkathy.bsky.social · 02/01/2026
I don't think you non-science people realize what it takes to get a grant funded by NIH. Started experiments in Sept 2021 to generate 3 new mouse mutants to model human disease. Prelim dara shows they have relevant disease phenotypes worthy of study. Need a small grant first to characterize /1
7485155
Reposted by Sukrit Singh
John Chodera @jchodera.bsky.social · 27/12/2025
This is more than half the NSF's total annual budget.
01511
Sukrit Singh @sukritsingh92.bsky.social · 12/12/2025
New preprint! How many crystal structures do you need to trust your docking results? It turns out, if you know how your main scaffold binds in the pocket, not that many! Check out this work from recently-defended lab member @keysandcompounds.bsky.social On BioRxiv: www.biorxiv.org/content/10.1...
0112
Reposted by Sukrit Singh
Jess White @jessbwhite.bsky.social · 12/12/2025
I'm honored to share that I've been selected as a 2026 PhRMA Foundation Predoctoral Fellow in Drug Discovery. This fellowship will support my research assessing how clinically relevant missense mutations impact kinase activity. Read more about our work here.
161
Reposted by Sukrit Singh
Dr. Fiona @fionachembot.bsky.social · 17/11/2025
Are you a postdoc stuck in the US?! Is your research stalled or are you in any way affected by the whims of that unfettered madman? Interested in MD simulations of large biomolecules?! Consider joining me at the University of Freiburg! uni-freiburg.de/frias/call-f...
uni-freiburg.de
Call for Applications: Early Career Rescue Fellowship – Freiburg Institute for Advanced Studies
01616
Reposted by Sukrit Singh
bioRxiv Biophysics @biorxiv-biophys.bsky.social · 25/09/2025
How many crystal structures do you need to trust your docking results? www.biorxiv.org/content/10.1101/202…
073
Reposted by Sukrit Singh
AI x Bio Discovery @aixbiobot.bsky.social · 25/09/2025
How many crystal structures do you need to trust your docking results? [new] Accurate drug docking needs crystal struct. Template docking via mol. similarity helps w/ ltd. data.
How many crystal structures do you need to trust your docking results?Figure 2Figure 3Figure 4
042
Reposted by Sukrit Singh
Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 15/09/2025
DYK: 76% of MSK postdoctoral researchers are international, coming from more than 60 countries for training and mentorship that translates into scientific discoveries across the globe? 🌎 Learn more about our incredible MSK postdocs: #PostdocAppreciationWeek
mskcc.org
International Postdocs From 60 Countries Are Training at MSK in 2025
What inspires the outstanding young scientists who come from around the world to train at MSK?
032
Sukrit Singh @sukritsingh92.bsky.social · 09/07/2025
On Monday I took my Oath of Allegiance and become a Naturalized US Citizen! Huzzah!
Sukrit, dressed in a blue and gray suit, is standing in front of the stage at a Naturalization ceremony holding a US flag
6581
Reposted by Sukrit Singh
Vincent Voelz @voelzlab.bsky.social · 23/06/2025
Excited to share work now out in #JCIM @acs.org ! doi.org/10.1021/acs.... Alchemical free energy calculations are indispensable in computational drug design. We present an improved approach for optimizing the schedule of alchemical intermediates by minimizing thermodynamic length. 1/7
doi.org
Simple Method to Optimize the Spacing and Number of Alchemical Intermediates in Expanded Ensemble Free Energy Calculations
Alchemical free energy calculations are essential to modern structure-based drug design. Such calculations are usually performed at a series of discrete intermediates along a nonphysical thermodynamic...
1143
Reposted by Sukrit Singh
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 25/03/2025
📢Important announcement! Today, the @asapdiscovery.bsky.social consortium disclosed the structure of our preclinical candidate, ASAP-0017445, a promising broad-spectrum antiviral with potent activity against SARS-CoV2 and other viruses belonging to the same family. (1/10)
35021
Reposted by Sukrit Singh
John Chodera @jchodera.bsky.social · 25/03/2025
This is the moment we've worked toward for a long time: First public disclosure of the @asapdiscovery.bsky.social pan-coronavirus antiviral aiming to help keep humanity safe from future pandemic threats like MERS-CoV and other bat coronaviruses.
49336
Sukrit Singh @sukritsingh92.bsky.social · 14/03/2025
Happy Holi, from the @jchodera.bsky.social lab!!
Five people, covered in bright Holi powder, stand arm-in-arm in front of a waterfront railing with a cityscape in the background. They’re all smiling and wearing colorful, powder-stained clothes.
0282
Sukrit Singh @sukritsingh92.bsky.social · 10/03/2025
This work is now published in J Phys Chem B! Check out our work showing that simulations predict the impact of distal mutations on kinase-inhibitor binding, and our experimental NanoBRET dataset of 94 kinase mutations that provide a benchmark for future methods. Link: pubs.acs.org/doi/full/10....
Illustration showing a pipeline for predicting the impact of ABL1A kinase domain mutations on inhibitor binding. On the left, icons labeled 'Physics-based simulations' and 'Data-driven methods' feed into 'Prospective ΔΔG Predictions.' On the right, a 3D ribbon model of the ABL1A kinase domain (gray) highlights clinically observed mutations in orange and an inhibitor in blue.
0299
Reposted by Sukrit Singh
C. Brandon Ogbunu @cbo.bsky.social · 06/03/2025
"No one is coming out of the sky to give you your grant money. Your citation portfolio won’t survive this market crash. Your credentials mean nothing. Everything is going to change." New for @undark.org undark.org/2025/03/06/o...
undark.org
How Science Can Adapt to a New Normal
Opinion | In the wake of attacks on the research enterprise, scientists need to focus on protecting its fragile infrastructure.
516879
Reposted by Sukrit Singh
Prasad Jallepalli, MD, PhD @prasad.bsky.social · 01/03/2025
NIH operates three cycles of grant review, approval for funding, and actual notice of award right now all three cycles are blocked if noncompeting awards are frozen, that's a fourth block American science is running out of oxygen because of an acute airway obstruction
819692
Sukrit Singh @sukritsingh92.bsky.social · 27/02/2025
It's important to communicate to the public the importance of basic science. Coco is happy to help explain drug binding mechanisms and enzyme kinetics basics: #scicomm
Composite image illustrating enzyme inhibition concepts with a black dog in different poses:

Top-left: The dog wears a pink flying disc on its head, labeled “Non-competitive (allosteric) inhibition (E–Inc).”
Center: The dog in a tub, tongue out, labeled “E,” connected to “E–S” (enzyme–substrate).
Top-right: The dog holding a yellow tennis ball, labeled “Competitive inhibition (E–Ic).”
Bottom-center: The dog chewing a blue ball, labeled “Substrate binding.” Arrows and labels show the relationships between each form of the enzyme.
Composite image demonstrating “good” versus “bad” enzyme–substrate binding with the same black dog:

Left: The dog with a blue ball in its mouth, labeled “E–Sᵍ” (“bad” binding mode).
Center-left: The dog in a tub with tongue out, labeled “E.”
Center-right: The dog holding a blue ball in a more controlled way, labeled “E–S” (“good” binding mode).
Far right: The dog beside shredded toy pieces, labeled “E + P” (product formation). Text labels and arrows illustrate the transition from enzyme–substrate complexes to products.
052
Reposted by Sukrit Singh
Annika Barber @annikabarber.bsky.social · 24/02/2025
Wondering if your study section cancelled? I update this sheet daily. As of today, 56/124 study sections that should have met since Jan 2, 2025 have "not met as scheduled." docs.google.com/spreadsheets...
docs.google.com
2025 Study section tracking
44365287
Reposted by Sukrit Singh
Valerie Horsley @valeriejhorsley.bsky.social · 24/02/2025
Please share: @delauro.house.gov is cochair of the US House Congressional Rapid Response Task Force and Litigation Working Group. They are looking for instances where the impoundment and restriction of NIH/NSF funds is having a negative impact. Submit examples here delauro.house.gov/constituent-...
delauro.house.gov
2025 Federal Financial Assistance Freeze
On Monday, January 27th, 2025, President Trump issued an order to freeze virtually all of approved and legally required federal funding.
6139210
Reposted by Sukrit Singh
Blue Wave 🌊 2026•2028🗽 @jmzmuda.bsky.social · 23/02/2025
An #NIH-funded research team has developed an mRNA vaccine to treat pancreatic cancer. Results from the clinical trial were published this week in Nature. #pancreas #cancer #mRNA #vaccine #medsky #science #medicine #bluesky
mskcc.org
In Early-Phase Pancreatic Cancer Clinical Trial, Investigational mRNA Vaccine Induces Sustained Immune Activity in Small Patient Group
Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
13956141249
Reposted by Sukrit Singh
Jeremy Berg @jeremymberg.bsky.social · 22/02/2025
Graduate admissions being put on hold because of the chaos...
512793
Reposted by Sukrit Singh
John Chodera @jchodera.bsky.social · 21/02/2025
Excited to share what I’ve been working on with @tkaraletsos.bsky.social to transform the field of drug discovery with atomistic foundation simulation models! I could not be more thrilled to be working with this dream team. achira.ai
99017
Reposted by Sukrit Singh
Sonya @sonyahanson.bsky.social · 17/02/2025
We are hiring a Flatiron Research Fellow in the Structural Molecular Biophysics team! Experience with cryoEM and/or membrane protein simulations are a plus! Happy to chat in person with anyone at #bps2025 ! apply.interfolio.com/160227
apply.interfolio.com
Apply - Interfolio {{$ctrl.$state.data.pageTitle}} - Apply - Interfolio
13019
Reposted by Sukrit Singh
John Chodera @jchodera.bsky.social · 19/02/2025
Everything is chaos, but I wanted to share some awesome recent science from the lab that hints at where the future of biomolecular simulation is headed: Foundation simulation models that can be fine-tuned to experimental free energy data to produce systematically more accurate predictions.
Figure 1 from arXiv preprint https://doi.org/10.1101/2025.01.06.631610

Fig. 1 Espaloma is an end-to-end differentiable molecular mechanics parameter assignment scheme for arbitrary organic molecules. Espaloma (extensible surrogate potential optimized by message-passing) is a modular approach for directly computing molecular mechanics force field parameters FFF from a chemical graph G such as a small molecule or biopolymer via a process that is fully differentiable in the model parameters FNN. In Stage 1, a graph neural network is used to generate continuous latent atom embeddings describing local chemical environments from the chemical graph. In Stage 2, these atom embeddings are transformed into feature vectors that preserve appropriate symmetries for atom, bond, angle, and proper/improper torsion inference via Janossy pooling.54 In Stage 3, molecular mechanics parameters are directly predicted from these feature vectors using feed-forward neural networks. This parameter assignment process is performed once per molecular species, allowing the potential energy to be rapidly computed using standard molecular mechanics or molecular dynamics frameworks thereafter. The collection of parameters FNN describing the espaloma model can be considered as the equivalent complete specification of a traditional molecular mechanics force field such as GAFF38,39/AM1-BCC55,56 in that it encodes the equivalent of traditional typing rules, parameter assignment tables, and even partial charge models. Reproduced from ref. 49 with permission from the Royal Society of Chemistry.
310530
Reposted by Sukrit Singh
Greg Bowman @drgregbowman.bsky.social · 16/02/2025
Nice time catching up with folks from @foldingathome.org at #bps2025
1294
Reposted by Sukrit Singh
Mark Polk @handle.invalid · 16/02/2025
Excited to be in LA for #BPS2025 @biophysicalsoc.bsky.social! I’ll be presenting a poster on our high-throughput fluorescence-based assay for kinase inhibitor binding in the West Exhibit Hall on Monday at 2:45 PM (board B60).
184
Sukrit Singh @sukritsingh92.bsky.social · 16/02/2025
I'll be presenting my work prospectively studying clinical mutations and their impact on kinase inhibitor binding at #bps2025! Come see my talk on Wednesday morning @ 8:45am.
1359
Reposted by Sukrit Singh
Carl T. Bergstrom @carlbergstrom.com · 08/02/2025
1. Today the NIH director issued a new directive slashing overhead rates to 15%. I want to provide some context on what that means and why it matters. grants.nih.gov/grants/guide...
grants.nih.gov
NOT-OD-25-068: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates NOT-OD-25-068. OD
25470004078
Reposted by Sukrit Singh
Tori Barber @vbarber.bsky.social · 28/01/2025
**screams in early career scientist**
622029
Reposted by Sukrit Singh
Claus Wilke @clauswilke.com · 17/12/2024
Bioart, courtesy of the NIH. All images are in the public domain and available for download as high-quality SVGs. bioart.niaid.nih.gov
14448170
Sukrit Singh @sukritsingh92.bsky.social · 09/12/2024
Excellent winter vacation vibes: A book on the Science of Indian cooking (from Krish Ashok) paired with an amazing coconut-washed Old Fashioned from Dishoom.
A view of an indoor lounge in the restaurant Dishoom in London. In the middle is a coffee table which has a cocktail and a book. The cocktail is an Old Fashioned that came in a bottle and a separate glass of ice to pour small amounts into. The book is Masala Lab from Krish Ashok on the Science of Indian cooking
2150
Sukrit Singh @sukritsingh92.bsky.social · 03/12/2024
With the help of new technician @markpolk.bsky.social, we've got our wet lab robots rapidly (and consistently) measuring kinase-inhibitor binding! Stay tuned for more:
A graph plotting a series of fluorescence spectra, each curve measuring kinase-inhibitor at a different drug concentration (the drug concentration is indicated in the color legend on the right). A dose-response curve from the full spectra, corrected for native ligand fluorescence, reporting drug binding over a series of inhibitor concentrations
1213
Reposted by Sukrit Singh
Folding@home @foldingathome.org · 03/12/2024
Too many requests for money this Giving Tuesday? Consider giving your spare CPU/GPU cycles to advance biomedical research instead! Download our software and join our community of citizen scientists here: foldingathome.org/start-folding/
foldingathome.org
Start Folding – Folding@home
2106
Reposted by Sukrit Singh
Polaris @polarishub.io · 03/12/2024
🦠 We’re excited to announce our first competition in partnership with @asapdiscovery.bsky.social and @omsf.io! Test your skills across three sub-challenges revolving around SARS-CoV-2 and MERS-CoV Mpro🧵 Full details: polarishub.io/competitions Blog: polarishub.io/blog/antivir...
14316
Reposted by Sukrit Singh
Mark Polk @handle.invalid · 27/11/2024
Automated plate handling in the Chodera Lab, part of our effort to study kinase inhibitors in high throughput.
0204
Reposted by Sukrit Singh
Folding@home @foldingathome.org · 25/11/2024
To keep up with individual Folding@home researchers (past and present), check our FAH Researcher starter pack! We'll do our best to keep it up to date, so check back every so often. Link: go.bsky.app/AMkfpEq
12410
Reposted by Sukrit Singh
MSKEducation @mskeducation.bsky.social · 25/11/2024
Checkout the latest work by our #MSKPostdoc @sukritsingh92.bsky.social
043
Reposted by Sukrit Singh
Ian Outhwaite @iouthwaite.bsky.social · 25/11/2024
Starting off the week with scones and a recent preprint led by @sukritsingh92.bsky.social! Very cool comparative evaluation of mutation affinity prediction methods. Interesting differences in performance for das/imat, possibly due to conf-associated effects w/ the TII TKI
131